evaluation of prognostic and predictive factors in pediatric acute lymphoblatic leukemia patients admitted to shahid sadoughi hospital
Clicks: 237
ID: 166917
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
237 views
48 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #4 of 5 articles by views in corporate strategy and firm growth: creating value for shareholders
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Introduction: The most common neoplasm in childhood is acute leukemia and about 30% of all cancers are luekemias. Treatment based on prognostic factors has improved survival rate during the last two decades. As prognostic factors differ in different populations, this study was done to evaluate the factors in Yazd. Methods: This descriptive observational study was done as a case series study. The population under study included 56 children in the age range of 0-14 years and all of them were admitted to Shahid Sadoghi Hospital of Yazd. To obtain predicting clinical (age, gender.hepatomegaly…) and laboratory (CBC, LDH, Flow cytometry…) factors in outcome of disease (Relapse and death), statistic technique of Cox Proportional Hazard Ratio and chi-square tests were used. All prognostic factors were with univariate and multivariate analyses. Results: Only WBC count 50000 in both univariate and multivariate analyses was predictive factor for death. (p.v:0.008, HR: 21.77, 95% CI=2.33 -75.11). Conclusion: Patients with WBC count 50000 were 22 times more at risk of death than those with lesser counts. Therefore, these patients should be considered as a high risk group.
| Reference Key |
rafieyan2009majallah-ievaluation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;M Rafieyan;M Kheirandish;A Bahrami Ahmadi;Z Eslami;MA Manochehri naieni;A Hashemi |
| Journal | corporate strategy and firm growth: creating value for shareholders |
| Year | 2009 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.